CD44 and familial pancreatic carcinoma: These data indicate that TP53INP1, LATS2 and CD44 are direct targets of miR-373 in pancreatic cancer, and provide experimental evidence of the mechanism by which the ZIP4-miR-373 pathway promotes pancreatic tumour growth through the inhibition of key tumour suppressor genes.